Source: Medical Marijuana Inc. and HempMeds Press Release July 31 2014
HempMeds Showcases World’s First Cannabidiol (CBD)-Rich Hemp Oil Products Available in All 50 States and More Than 40 Countries to Global Buyers in Las Vegas at ASD
SAN DIEGO, July 31, 2014 (GLOBE NEWSWIRE) — Global retailers are seeing what is trending in worldwide news headlines: cannabidiol (CBD), a natural constituent of the hemp plant. Countering claims that “CBD-only” laws are required to purchase or resell CBD-rich hemp oil products from HempMeds, the Company is exhibiting at ASD in Las Vegas August 3-6 at the Las Vegas Convention Center.
There, HempMeds™ will proudly display more than one dozen of the world’s first line of CBD-rich hemp oil personal care, nutritional supplements and lifestyle products. Research shows that many cannabinoids have anti-oxidant properties, which is adding to the growing interest in CBD-rich hemp oil products.
“That’s right – today is the day that consumers will see cannabis and CBD-rich hemp oil products in convenience and retail stores,” states Andrew Hard, Director of Public Relations for HempMeds™. “CBD-rich hemp oil products are starting to play a large role in the global anti-aging and nutritional products markets. According to the American Academy of Anti-Aging Medicine (A4M), estimates on the value of the anti-aging market are $292 billion globally by 2015; in the same timeframe, the global nutraceutical market is projected to exceed $243 billion. These numbers speak volumes. HempMeds is proud to be the largest supplier of CBD-rich hemp oil in the world.”
It is important to note CBD-rich hemp oil does not have the psychoactive effect that THC in marijuana has, and that the CBD-rich hemp oil products that HempMeds™ represents are available in all fifty states and more than forty countries.
From “seed to sale,” compliance is mandatory with multi-national government agencies in order to import hemp oil. Once imported, the CBD-rich hemp oil undergoes further internal testing and third-party analysis prior to creating retail products. Although CBD does not yet have organic status, all-natural CBD-rich hemp oil does not contain pesticides or herbicides.
HempMeds™ is displaying the following CBD-rich hemp oil products at ASD from exhibit SL5267: Real Scientific Hemp Oil™ (RSHO™) a super-concentrated CBD-rich hemp oil; Cibdex™ vegan capsules and flavored drops; and Cibaderm™ personal care products: shampoo, conditioner, body wash, body lotion, hand cream and salve.
Also from the booth, Mr. Hard and other HempMeds™ representatives will discuss CBD-only laws, CBD-rich hemp oil products that are available nationwide, and the arrival of cannabis products in convenience and retail stores across the nation.
ASD is a premier global buyers’ expo featuring “seven shows in one.” Although the full line of CBD-rich hemp oil products on display by HempMeds™ at ASD can be classified into several categories, exhibit SL5267 is located in the south lower wing of the Las Vegas Convention Center.
For more information on CBD-rich hemp oil products, please visit:
HempMeds™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT: For further information, please contact: Andrew Hard Director of PR, HempMeds P. 858-380-5478 [email protected]